(IN BRIEF) The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMAs) have jointly released a comprehensive Artificial Intelligence (AI) workplan outlining their collaborative strategy through 2028. This initiative aims to maximize the benefits of AI for stakeholders … Read the full press release
Posted in Artificial Intelligence (AI), Business, Environment, European Union, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged 2028 Workplan, artificial-intelligence, EMA, HMAs, Medicines Regulation, partnership, sustainability
(IN BRIEF) In a significant development for Africa’s pharmaceutical sector, the African Pharmaceutical Technology Foundation and the Rwandan Government have signed a host country agreement, paving the way for the Foundation’s operationalization. The Foundation has also forged a memorandum of … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Pharma & Biotech, Technology
Tagged Africa, African Development Bank, African Pharmaceutical Industry, African Pharmaceutical Technology Foundation, Dr Akinwumi Adesina, Dr Bärbel Kofler, Dr Ngozi Okonjo-Iweala, Dr Tedros Adhanom Ghebreyesus, Dr Vincent Biruta, EIB, Gelsomina Vigliotti, partnership, Professor Padmashree Gehl Sampath, sustainability
(IN BRIEF) Roche (SIX: RO, ROG; OTCQX: RHHBY) has once again secured its position as one of the leading sustainable companies in the Pharmaceuticals sector within the Dow Jones Sustainability Indices (DJSI). In the latest rankings, Roche secured the third … Read the full press release
(IN BRIEF) Novadip, a Belgian biotech company, has secured €18 million in venture debt financing from the European Investment Bank (EIB) with support from the European Union’s InvestEU initiative. The funds will be utilized for clinical trials of NVD-003, an … Read the full press release
(IN BRIEF) The European Investment Bank (EIB) has signed a €70 million loan agreement with Stichting Vivium Zorggroep to support the organization’s investment plans until 2030. Vivium plans to modernize its building management approach, adapt its facilities for new care … Read the full press release
Posted in Banks, Business, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Luxembourg, Management, Netherlands, News, Real Estate
Tagged Elderly Care Facilities, Erwin Melger, European Investment Bank, Kris Peeters, Marco Wisse, Netherland, partnership, sustainability, Vivium Zorggroep
(IN BRIEF) Roche, a global pharmaceutical company, has shared compelling data from its CD20xCD3 T-cell engaging bispecific antibody program during the 65th American Society of Hematology (ASH) Annual Meeting & Exposition held in December 2023. The data includes extended follow-up … Read the full press release
(IN BRIEF) In a significant development, GSK plc has received marketing authorization from the European Commission (EC) for Jemperli (dostarlimab) in combination with carboplatin-paclitaxel chemotherapy as a treatment option for adult patients suffering from mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) … Read the full press release
(IN BRIEF) In the Phase 3 IsKia trial presented at the American Society of Hematology (ASH) Annual Meeting, Sarclisa® (isatuximab) combined with carfilzomib, lenalidomide, and dexamethasone (KRd) demonstrated a significant improvement in achieving minimal residual disease (MRD) negativity among newly … Read the full press release
Posted in Business, Education, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged carfilzomib, Combination Therapy, dexamethasone, Francesca Gay, lenalidomide, Myeloma, Peter C. Adamson, Phase 3 Trial, Remission Rates, Sanofi, Sarclisa
(IN BRIEF) Roche has released positive long-term follow-up data from the Phase III KATHERINE study, evaluating Kadcyla® (trastuzumab emtansine) as adjuvant therapy for people with HER2-positive early-stage breast cancer (eBC) who have residual invasive disease following neoadjuvant treatment. The study … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Science, Switzerland, Technology
Tagged breast cancer, HER2-Positive, Kadcyla, Levi Garraway, Long-Term Survival, Phase III KATHERINE, Prof. Dr. Sibylle Loibl, Roche
(IN BRIEF) Roche has announced promising results from the Phase III INAVO120 study, which evaluated inavolisib in combination with palbociclib (Ibrance®) and fulvestrant as a first-line treatment for individuals with PIK3CA-mutated, hormone receptor (HR)-positive, HER2-negative, endocrine-resistant, locally advanced, or metastatic … Read the full press release
(IN BRIEF) The COMBINE-CT consortium, led by Philips and supported by a €6.5 million grant from the Innovative Health Initiative (IHI), is dedicated to improving the diagnosis and treatment of coronary artery disease (CAD). CAD, characterized by the accumulation of … Read the full press release
(IN BRIEF) Sanofi is showcasing its ambitious pipeline transformation strategy, which includes a record 12 potential blockbuster opportunities currently under clinical evaluation. Among these, there are nine innovative medicines and vaccines with peak sales potential ranging from €2 to €5 … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Technology
Tagged Houman Ashrafian, Immunology Industry, Paul Hudson, Sanofi
(IN BRIEF) The Phase 3 IMROZ trial, assessing the use of Sarclisa® (isatuximab) in combination with standard-of-care bortezomib, lenalidomide, and dexamethasone (VRd), has achieved its primary efficacy endpoint at a planned interim analysis. The trial demonstrated a statistically significant improvement … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology
Tagged Dietmar Berger, IMROZ trial, Multiple Myeloma Patients, Sanofi, Sarclisa, Thierry Facon
(IN BRIEF) The North Cumbria Integrated Care NHS Foundation Trust, GRAHAM, and CCL Solutions have been honored with the ICW Collaborative Working Award for their successful collaboration in delivering critical healthcare construction projects. This partnership, which implemented ISO44001 collaborative practices, … Read the full press release
Posted in Awards, Business, Construction, Environment, Financial, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, United Kingdom
Tagged Award, CCL Solutions, GRAHAM, Healthcare Projects, Keith Hayes, North Cumbria NHS Trust, partnership, Stephen Prince, sustainability
(IN BRIEF) Roche, a leading pharmaceutical company, has announced its definitive merger agreement to acquire Carmot Therapeutics, a privately owned US-based company specializing in obesity treatment and related metabolic diseases. The acquisition includes Carmot’s portfolio of clinical stage subcutaneous and … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged acquisition, Carmot Therapeutics, CT-388, Levi Garraway, metabolic disease, Obesity Treatment, Roche, Thomas Schinecker, USA
(IN BRIEF) Professor Laura Bojke, an esteemed expert in health economics from the University of York’s Centre for Health Economics, has been named the Inaugural Chair of the World Health Organization (WHO) Advisory Group on Economics for Environment, Climate Change, … Read the full press release
(IN BRIEF) Sanofi’s Consumer Healthcare business unit (CHC) has introduced the Shared Care Collective, an advisory board consisting of experts from various fields, both internal and external, to bolster sustainability efforts within the CHC business. This initiative aims to foster … Read the full press release
(IN BRIEF) Dr. Edward Emmott, a researcher at the University of Liverpool, has received the prestigious Wellcome Trust Career Development Award, a highly competitive fellowship. This funding will support Dr. Emmott’s crucial research efforts aimed at gaining a deeper understanding … Read the full press release
(IN BRIEF) Despite technological advancements, the long-term survival of transplanted kidneys has seen little improvement in the past two decades, with approximately 40% of transplanted kidneys being rejected within ten years. In response, the Nierstichting and NWO are collaborating in … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged health, Kidney Transplant Survival, Nierstichting, NWO, partnership, sustainability
(IN BRIEF) A groundbreaking miniaturized spectroscopy module has been created through a partnership between trinamiX, LUMILEDS, and VIAVI Solutions. Designed to run on Qualcomm Technologies’ Snapdragon® 8 Gen 3 reference design, the module brings near-infrared (NIR) spectroscopy to smartphones. This … Read the full press release
Posted in Business, Electronics & Machinery, Germany, Healthcare, Technology, Telecom
Tagged 2023 Qualcomm Snapdragon Summit, Adam Scheer, biomarkers, detector, filter manufacturers, health indicators, LED light sources, light shaping optics, light source, LUMILEDS, Near-infrared spectroscopy, NIR spectroscopy modules, Noman Rangwala, optical filters, Qualcomm Technologies, smartphones, Snapdragon Summit 2023, Snapdragon® 8 Gen 3, spectrometers, trinamiX, VIAVI Solutions, Wilfried Hermes
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?